Futura Medical plc
FUM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £1,001 | £6,925 | £7,001 | £1,398 |
| % Growth | -85.5% | -1.1% | 400.9% | – |
| Cost of Goods Sold | £758 | £2,119 | £2,239 | £532 |
| Gross Profit | £243 | £4,806 | £4,761 | £865 |
| % Margin | 24.3% | 69.4% | 68% | 61.9% |
| R&D Expenses | £762 | £1,133 | £609 | £1,227 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £6,206 | £3,377 | £3,332 | £4,643 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | -£59 | £0 | £0 |
| Operating Expenses | £6,967 | £4,450 | £3,942 | £5,870 |
| Operating Income | -£6,724 | £297 | £820 | -£5,005 |
| % Margin | -671.6% | 4.3% | 11.7% | -358.1% |
| Other Income/Exp. Net | £38 | £128 | £47 | £0 |
| Pre-Tax Income | -£6,686 | £424 | £867 | £0 |
| Tax Expense | -£100 | £133 | -£135 | £4,751 |
| Net Income | -£6,586 | £291 | £1,002 | -£4,751 |
| % Margin | -657.8% | 4.2% | 14.3% | -340% |
| EPS | -0.022 | 0.001 | 0.003 | -0.016 |
| % Growth | -2,270% | -69.7% | 120.2% | – |
| EPS Diluted | -0.022 | 0.001 | 0.003 | -0.016 |
| Weighted Avg Shares Out | 303,821 | 291,369 | 301,503 | 291,943 |
| Weighted Avg Shares Out Dil | 303,821 | 291,369 | 317,437 | 291,943 |
| Supplemental Information | – | – | – | – |
| Interest Income | £38 | £0 | £47 | £72 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £62 | £62 | £59 | £65 |
| EBITDA | -£6,624 | £487 | £926 | -£4,940 |
| % Margin | -661.6% | 7% | 13.2% | -353.5% |